NextCure Inc
General ticker "NXTC" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $30.6M
NextCure Inc does not follow the US Stock Market performance with the rate: -5.0%.
Estimated limits based on current volatility of 5.5%: low 0.88$, high 0.98$
Factors to consider:
- Price in estimated range
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [0.81$, 2.27$]
- 2024-12-30 to 2025-12-30 estimated range: [1.22$, 3.04$]
Financial Metrics affecting the NXTC estimates:
- Negative: Non-GAAP EPS, $ of -2.25 <= 0.10
- Negative: Operating profit margin, % of -100 <= 1.03
- Negative: Operating cash flow per share per price, % of -61.06 <= 2.35
- Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85
- Positive: Interest expense per share, $ of 0 <= 0
- Negative: negative Net income
- Negative: Industry earnings per price (median), % of -26.04 <= 1.31
Short-term NXTC quotes
Long-term NXTC plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $70.77MM | $75.91MM | $67.64MM |
| Operating Income | $-70.77MM | $-75.91MM | $-67.64MM |
| Non-Operating Income | $1.38MM | $1.18MM | $4.91MM |
| Interest Expense | $0.08MM | $0.00MM | $0.00MM |
| R&D Expense | $50.19MM | $54.20MM | $47.93MM |
| Income(Loss) | $-69.39MM | $-74.73MM | $-62.72MM |
| Profit(Loss) | $-69.39MM | $-74.73MM | $-62.72MM |
| Stockholders Equity | $233.39MM | $167.53MM | $114.42MM |
| Inventory | $0.00MM | $0.70MM | $0.00MM |
| Assets | $242.39MM | $184.16MM | $128.04MM |
| Operating Cash Flow | $-57.28MM | $-53.89MM | $-52.97MM |
| Capital expenditure | $2.36MM | $2.12MM | $0.82MM |
| Investing Cash Flow | $36.60MM | $67.98MM | $39.27MM |
| Financing Cash Flow | $-3.27MM | $0.20MM | $0.15MM |
| Earnings Per Share* | $-2.51 | $-2.50 | $-2.25 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.